Crispr Therapeutics shares owned by Baird Financial
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Baird Financial
from 13F filings
Historical chart of Baird Financial investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Baird Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Baird Financial
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $2.0M | 30k | 68.16 |
2022-06-30 | $236k | 3.9k | 60.62 |
2021-09-30 | $284k | 2.5k | 111.90 |
2021-06-30 | $464k | 2.9k | 161.73 |
2021-03-31 | $374k | 3.1k | 121.74 |
2020-12-31 | $305k | 2.0k | 153.11 |